Fast Five Quiz: Alzheimer Disease Management

Jasvinder P. Chawla, MD, MBA

Disclosures

May 23, 2019

Early diagnosis and treatment of Alzheimer disease are essential for patients to maintain the highest levels of cognitive and functional abilities. To facilitate early diagnosis and treatment, ongoing initiatives in the United States and Europe aim to identify precursors associated with Alzheimer disease (eg, environmental and genetic risk factors, alcohol use disorders, poor-quality sleep, gut-brain links). In addition, early intervention strategies (eg, physical activity, ChEIs combined with mental exercises, experimental therapies) are used to prevent or delay the deterioration of cognition in patients with Alzheimer disease. Experimental therapies in the United States and Europe are now focusing on early prevention and detection rather than treating later-stage disease.

Antidepressants and benzodiazepines are often helpful for secondary effects of Alzheimer disease, but do not yield the highest levels of cognitive and functional abilities.

Loop diuretics, CCBs, or daily jogging do not yield the highest levels of cognitive and functional abilities for patients with Alzheimer disease.

For more on early diagnosis and treatment of Alzheimer disease, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....